Hypersomnia and depressive symptoms: methodological and clinical aspects
about
Update of sleep alterations in depressionEfficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysisCortical-subcortical interactions in hypersomnia disorders: mechanisms underlying cognitive and behavioral aspects of the sleep-wake cycle.Poor Sleep in Multiple Sclerosis Correlates with Beck Depression Inventory Values, but Not with Polysomnographic Data.Incidence, worsening and risk factors of daytime sleepiness in a population-based 5-year longitudinal study.Excessive daytime sleepiness among rural residents in SaskatchewanNatural history of excessive daytime sleepiness: role of obesity, weight loss, depression, and sleep propensity.Hypersomnia in Mood Disorders: a Rapidly Changing LandscapePhysiological Sleep Propensity Might Be Unaffected by Significant Variations in Self-Reported Well-Being, Activity, and MoodThe Humanistic and Economic Burden of Narcolepsy.Subjective and Objective Measures of Hypersomnolence Demonstrate Divergent Associations with Depression among Participants in the Wisconsin Sleep Cohort Study.Sleep Duration Associated with the Lowest Risk of Depression/Anxiety in Adolescents.Sex differences in sleep, anhedonia, and HPA axis activity in a rat model of chronic social defeat.Sleep propensity in psychiatric hypersomnolence: A systematic review and meta-analysis of multiple sleep latency test findings.Dad's Snoring May Have Left Molecular Scars in Your DNA: the Emerging Role of Epigenetics in Sleep Disorders.Objective measures of sleep duration and continuity in major depressive disorder with comorbid hypersomnolence: a primary investigation with contiguous systematic review and meta-analysis.Changes in Sleep Duration During Transition to Statutory Retirement: A Longitudinal Cohort Study.Hypersomnolence, Hypersomnia, and Mood Disorders.Longitudinal associations of hypersomnolence and depression in the Wisconsin Sleep Cohort Study.Behavioral Sleep Medicine Services for Hypersomnia Disorders: A Survey Study.[18F]Fludeoxyglucose-Positron Emission Tomography Evidence for Cerebral Hypermetabolism in the Awake State in Narcolepsy and Idiopathic Hypersomnia.Test-Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence.Absence of γ-aminobutyric acid-a receptor potentiation in central hypersomnolence disorders.
P2860
Q26781426-D48C895F-AC33-470B-B266-F9B33377D026Q28535752-3463F922-68BC-4994-9F34-B69CF4C23355Q30859644-24826723-ABD1-4CFE-97C5-44E054F04941Q31046728-E65D8BEF-A770-4AFF-88AC-569BABFE3722Q33683837-C5568A72-DFD6-41EE-84FD-F2BD5D72D4FEQ34238209-CD305066-41DD-47C2-B8FA-F3018C4E1CDCQ35104925-18032708-0465-4651-89BC-A9A795A562A0Q35920392-EB93027D-C1EC-4F91-819E-680DCB555877Q35947315-53B08D11-122E-49AD-99E7-D5EADB9FA407Q36637764-DB29C5AE-7F4F-40D1-BF6C-EF030CE2E3D2Q36696068-280B45DA-0A58-4A2E-81DC-F6031B7AC50AQ37095510-8FBED6B0-C88D-443D-8B1C-FD6D9BD60CCFQ37486906-CF31713B-D643-4125-B3F7-4EA724C5E531Q38736201-193F65AC-4B5B-46EA-AED0-97F4EC85B50FQ38762350-EF83CBF2-7017-4420-BA42-15BF3F44AE9AQ38763450-BB88EDA9-73BA-45E4-9CB7-945FB03D02B4Q38765536-4F365AF3-22BA-43E5-8BCF-EAD8B27549FFQ39153990-91926D76-0D35-4DDF-91F5-CF58C7BCC289Q39305854-CEA39CDC-452D-41A6-BF0B-6A11B32044DCQ40084399-A873BAB0-31C4-4BF5-AB35-43BDA0F06038Q41061446-5C427083-A323-4566-A486-57D6561E57E9Q47666425-0978027A-03DC-4613-8B40-3BC1196C043CQ48548130-8648912C-E270-4797-BE99-BC9C9E7D1D7D
P2860
Hypersomnia and depressive symptoms: methodological and clinical aspects
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Hypersomnia and depressive symptoms: methodological and clinical aspects
@ast
Hypersomnia and depressive symptoms: methodological and clinical aspects
@en
Hypersomnia and depressive symptoms: methodological and clinical aspects
@nl
type
label
Hypersomnia and depressive symptoms: methodological and clinical aspects
@ast
Hypersomnia and depressive symptoms: methodological and clinical aspects
@en
Hypersomnia and depressive symptoms: methodological and clinical aspects
@nl
prefLabel
Hypersomnia and depressive symptoms: methodological and clinical aspects
@ast
Hypersomnia and depressive symptoms: methodological and clinical aspects
@en
Hypersomnia and depressive symptoms: methodological and clinical aspects
@nl
P2093
P2860
P356
P1433
P1476
Hypersomnia and depressive symptoms: methodological and clinical aspects
@en
P2093
Maurice Ohayon
Régis Lopez
Yves Dauvilliers
P2860
P2888
P356
10.1186/1741-7015-11-78
P407
P5008
P577
2013-03-21T00:00:00Z
P5875
P6179
1043005222